Schedule 13G Filing for Bionano Genomics, Inc. by Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC

This Schedule 13G filing discloses the beneficial ownership of shares of Bionano Genomics, Inc. by Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC. As of September 19, 2025, each of the Reporting Persons may have been deemed to have beneficial ownership of 508,415 shares of Common Stock, representing approximately 4.99% of the Common Stock. The filing details the ownership structure, including the impact of blocker provisions in warrants held by Intracoastal Capital LLC, which limit the exercise of these warrants to prevent beneficial ownership from exceeding 4.99% of the Common Stock. The filing also includes a Joint Filing Agreement, acknowledging that the statement is filed on behalf of each of the undersigned and that subsequent amendments may be filed without additional joint filing agreements.